tiprankstipranks
Perrigo reports Q3 adjusted EPS 81c, consensus 81c
PremiumThe FlyPerrigo reports Q3 adjusted EPS 81c, consensus 81c
3M ago
Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.56
Premium
The Fly
Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.56
3M ago
PRGO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PRGO Earnings this Week: How Will it Perform?
3M ago
Perrigo Announces Voluntary Recall, Maintains Fiscal Outlook
PremiumCompany AnnouncementsPerrigo Announces Voluntary Recall, Maintains Fiscal Outlook
6M ago
Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.25
Premium
The Fly
Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.25
6M ago
Perrigo reports Q2 adjusted EPS 53c, consensus 46c
Premium
The Fly
Perrigo reports Q2 adjusted EPS 53c, consensus 46c
6M ago
Perrigo completes divestment of HRA Pharma Rare Diseases business to Esteve
PremiumThe FlyPerrigo completes divestment of HRA Pharma Rare Diseases business to Esteve
7M ago
Perrigo price target lowered to $36 from $39 at Piper Sandler
Premium
The Fly
Perrigo price target lowered to $36 from $39 at Piper Sandler
7M ago
Perrigo Welcomes Todd Penegor to Board of Directors
Premium
Company Announcements
Perrigo Welcomes Todd Penegor to Board of Directors
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100